Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
- Most evidence comes from animal studies - Human data is extremely limited - No FDA approval for orthopedic use - Clinical benefit in musculoskeletal conditions remains unproven While the biology is interesting, potential does not equal proven clinical outcomes
RoB 2: a revised tool for assessing risk of bias in randomised trials
Track your storage conditions carefully when traveling
Therefore, the participant would receive a cost score on any of the quality measures for which they meet those minimum data and submission requirements as described in sections III.C.d.(2).(g) and III.C.2.d.(2).(h) of this final rule
US$ 29.37
US$ 29.35
US$ 20.67
